Your session is about to expire
← Back to Search
Metformin for Breast Cancer (HERMET Trial)
HERMET Trial Summary
This trial is testing whether metformin can help treat HER2 positive breast cancer when added to standard chemotherapy.
- HER2-positive Breast Cancer
HERMET Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHERMET Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 156 Patients • NCT02002221HERMET Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
When was Metformin accepted by the FDA as a medication?
"So far, Metformin has shown signs of safety in clinical trials but not efficacy, giving it a score of 2."
What else is known about Metformin from other investigations?
"Currently, 1335 clinical trials are ongoing that involve metformin. Of these, 410 are in phase 3. Many of the trials taking place in Seattle, Washington, but there are 74753 locations running studies for metformin globally."
What are the primary indications for Metformin?
"Metformin is frequently used to treat non-hodgkin lymphoma. However, Metformin can also be used as part of the initial treatment for diet and exercise not sufficient for diabetes control and metastatic bladder cancer."
Are we still recruiting volunteers for this experiment?
"This study, which is currently recruiting participants, was originally posted on August 15th, 2017 and was last updated on December 4th, 2021."
What is the total number of volunteers for this test?
"That is correct, the online information portal clinicaltrials.gov has indicated that this trial is still seeking patients. The posting went up on 8/15/2017 and was edited as recently as 12/4/2021. They are looking for 100 individuals to participate at 6 different hospitals or clinics."
Share this study with friends
Copy Link
Messenger